News

February 21, 2020February 21, 2020

Adding Keytruda to Chemo Slows Worsening in Advanced TNBC with PD-L1 Markers, Trial Finds

News

First-line treatment with Keytruda (pembrolizumab) and chemotherapy prolongs the time without disease worsening in people with advanced triple-negative breast cancer (TNBC) whose tumors are positive for the marker PD-L1, an interim ... Read more

February 19, 2020February 19, 2020

Tucatinib Granted FDA Priority Review for Advanced HER2-positive Breast Cancer

News

The U.S. Food and Drug Administration (FDA) has granted priority review to Seattle Genetics’ application seeking approval of its investigational therapy tucatinib, in combination with trastuzumab and Xeloda (capecitabine), for treating people with locally advanced inoperable or metastatic HER2-positive breast cancer. ... Read more

February 17, 2020February 17, 2020

Tutu Project’s Pilot Program Helps Breast Cancer Patients Directly With Daily Expenses

News

The Tutu Project has awarded its first direct grants to patients and families battling breast cancer, as part of a new pilot program to help patients with their daily ... Read more

February 14, 2020February 14, 2020

AutoNation Donates $720K to Breast Cancer Research Foundation

News

As part of its Drive Pink initiative, AutoNation has donated $720,000 to the Breast Cancer Research Foundation (BCRF) to support research aimed at disease prevention, diagnosis and treatment. The ... Read more

February 7, 2020

Study of Treatment Aiming to Prevent Advanced Breast Cancer’s Spread to Bone Doses 1st Patient

News

GlycoMimetics announced that the first patient with advanced breast cancer has been dosed in a Phase 1b clinical trial investigating the ability of its small molecule inhibitor, GMI-1359, to stop ... Read more

February 6, 2020February 12, 2020

Keytruda-Mektovi Combo Deemed Safe in Early Triple Negative Breast Cancer Trial

News

A combination of the immune checkpoint inhibitor Keytruda (pembrolizumab) and the melanoma therapy Mektovi (binimetinib) is safe and well-tolerated by people with advanced triple negative breast cancer, preliminary findings ... Read more

February 3, 2020

Researcher Awarded $462K NIH Grant to Study Effects of Endocrine Disruptors on Breast Cancer Risk in Young Women

News

Research efforts to understand the effects of endocrine-disrupting chemicals (EDCs) on breast cancer risk in young women have been given a boost with a $462,000 grant from the National ... Read more

January 31, 2020January 31, 2020

Susan G. Komen Tissue Bank Teams with LifeOmic to Advance Breast Cancer Research

News

A partnership between the Susan G. Komen Tissue Bank and LifeOmic, a software company, aims to help researchers globally gain insights into how breast cancer develops, and ways of better ... Read more

January 30, 2020February 5, 2020

Ziskin Prize Winners Will Collaborate to Further Immune Checkpoint Inhibitors for Treating Breast Cancer

News

Two prominent breast cancer scientists will use their shared $250,000 Stand Up To Cancer (SU2C) grant to collaborate on the development of new therapies for treating breast cancer — ... Read more

January 29, 2020January 29, 2020

Artificial Intelligence Could Aid in Breast Cancer Screening, Study Shows

News

An artificial intelligence model outperformed certified radiologists in diagnosing breast cancer from mammogram images, according to a new study. This suggests that the system could be used in clinical settings to ... Read more

Pin It on Pinterest